New paper - Review about ligands for SARS-CoV-2 spike protein

Excited to share fantastic news! We have a freshly published paper in Biotechnology Advances. In this work, the authors explore "Native, engineered and de novo designed ligands targeting the SARS-CoV-2 spike protein".

This work was developed under the scope of the #PURE_project, financed by the European Union's Horizon 2020. Congratulations to the authors! For more info: https://doi.org/10.1016/j.biotechadv.2022.107986